Executive or Senior Director Search & Evaluation Late TA Lead; Im, CV, or He

Executive or Senior Director Search & Evaluation Late TA Lead, (Im, CV, or He) at CSL Behring summary:

Senior leader role to head strategic sourcing and evaluation of later-stage external clinical assets (Phase 2 to marketed) across Immunology, Hematology, and Cardiovascular/Renal, managing TA Leads for early and late-stage search & evaluation. Responsibilities include developing S&E strategy and processes, leading cross-functional due diligence, engaging KOLs and external networks, and partnering with BD to advance and close deals. Requires 15+ years in biopharma, an advanced degree (MD/PhD), deep clinical expertise in the specified TAs, and global team leadership experience.

CSL's R&D organization is accelerating innovation to deliver greater impact for patients. With a project-led structure and a focus on collaboration, we’re building a future-ready team that thrives in dynamic biotech ecosystems. Joining CSL now means being part of an agile team committed to developing therapies that make a meaningful difference worldwide.

Could you be our next Executive or Senior Director Search & Evaluation Late TA Lead, (Im CV or He)? The job is in our King of Prussia PA, Waltham MA or Zurich Switzerland Office. This is a hybrid position and is onsite three days a week.

Position Description
Summary
​

The Executive Director of Search & Evaluation will lead strategic sourcing and evaluation of later-stage external clinical assets in Immunology, Hematology, and Cardiovascular/Renal therapeutic areas. In addition, this role will manage all TA Leads for Early and Late Stage. These leaders will focus on opportunities from Phase 2 through marketed drugs, requiring deep clinical expertise, strong engagement with external Key Opinion Leaders (KOLs) and clinical investigators, and a keen understanding of evolving standards of care.

The role is critical to shaping our portfolio through high-impact partnerships and transactions.​

Main
Responsibilities &
Accountabilities
​

• Lead and manage a team of early and late-stage Search & Evaluation TA Leads.​

• Develop the strategy and a consistent process for all Search & Evaluation activities.​

• Serve as the senior S&E leader within the TALT, influencing therapeutic strategy and integrating late-stage external innovation priorities into portfolio planning.​

• Lead proactive sourcing efforts for Phase 2 to marketed assets, identifying opportunities that align with TA strategy and unmet medical needs.​

• Co-lead internal meetings (with Early Search Lead) focused on evaluating and prioritizing New Product Opportunities (NPOs) within each CSL’s therapeutic areas. NPO meetings are strategic checkpoints where cross-functional teams review potential assets identified by Search and decide whether to advance them for further due diligence and deal negotiations​

• Engage extensively with external KOLs, clinical investigators, and networks to validate asset potential, understand trial designs & clinical endpoints, and anticipate competitive dynamics.​

• Maintain deep awareness of changing standards of care and competitive landscapes to inform sourcing priorities and deal strategy.​

• Drive cross-functional due diligence for late-stage assets, coordinating clinical, regulatory, commercial, and market access assessments to support governance decisions.​

• Partner closely with BD and Regional Ecosystem Leads to advance high-priority opportunities through negotiation and deal close, ensuring seamless handoff and execution​

• Represent the TA externally, leading sourcing activities at specialized conferences and building relationships with pharma, biotech, and clinical communities.​

Qualifications &
Experience
Requirements
​

• 15+ years in biopharma with significant experience in clinical development, external innovation, or business development.​

• Advanced degree required (MD, PhD, or equivalent).​

• Deep clinical expertise in Immunology, Hematology, or Cardiovascular/Renal therapeutic areas.​

• Proven track record of sourcing and closing late-stage deals and engaging with KOLs and clinical networks.​

• Strong understanding of regulatory pathways, market access, and competitive standards of care.​

• Experience leading a global team​

#LI-H…